These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 18235148

  • 1. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC, Sethi S, Specks U.
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.
    Cochrane Database Syst Rev; 2014 Oct 16; 2014(10):CD004293. PubMed ID: 25318831
    [Abstract] [Full Text] [Related]

  • 3. Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy.
    Liu H, Luo W, Gong S, Ding X.
    Intern Med J; 2016 Nov 16; 46(11):1318-1322. PubMed ID: 27554390
    [Abstract] [Full Text] [Related]

  • 4. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
    Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA.
    PLoS One; 2014 Nov 16; 9(10):e110681. PubMed ID: 25313791
    [Abstract] [Full Text] [Related]

  • 5. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
    Frigui M, Hmida MB, Jallouli M, Kechaou M, Frikha F, Bahloul Z.
    Saudi J Kidney Dis Transpl; 2010 Mar 16; 21(2):320-2. PubMed ID: 20228521
    [Abstract] [Full Text] [Related]

  • 6. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC, Mentor Consortium group.
    Nephron; 2015 Mar 16; 130(3):159-68. PubMed ID: 26087670
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep 16; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

  • 8. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
    Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachtman H.
    BMC Nephrol; 2007 Aug 06; 8():11. PubMed ID: 17683621
    [Abstract] [Full Text] [Related]

  • 9. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment.
    Lai WL, Yeh TH, Chen PM, Chan CK, Chiang WC, Chen YM, Wu KD, Tsai TJ.
    J Formos Med Assoc; 2015 Feb 06; 114(2):102-11. PubMed ID: 25558821
    [Abstract] [Full Text] [Related]

  • 10. [Idiopathic membranous nephropathy in an elderly patient with type 2 diabetes mellitus].
    Costero O, Díaz C, de Alvaro F, Torre A, Gil F, Picazo ML, Martínez-Ara J.
    Nefrologia; 2001 Feb 06; 21(4):402-5. PubMed ID: 11816518
    [Abstract] [Full Text] [Related]

  • 11. [Membranous glomerulonephritis].
    Scheidat S, Stahl RA.
    Internist (Berl); 2003 Sep 06; 44(9):1120-30. PubMed ID: 14566465
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 13. Membranous nephropathy in a 13-year-old boy with common variable immunodeficiency.
    Yim HE, Yoo KH.
    J Korean Med Sci; 2012 Nov 15; 27(11):1436-8. PubMed ID: 23166431
    [Abstract] [Full Text] [Related]

  • 14. Nonimmunosuppressive therapy of membranous nephropathy.
    Schieppati A, Ruggenenti P, Perna A, Remuzzi G.
    Semin Nephrol; 2003 Jul 15; 23(4):333-9. PubMed ID: 12923721
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF.
    Am J Kidney Dis; 2005 Dec 15; 46(6):1012-29. PubMed ID: 16310567
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy.
    van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF.
    J Am Soc Nephrol; 2014 Jan 15; 25(1):150-8. PubMed ID: 24029426
    [Abstract] [Full Text] [Related]

  • 17. Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy.
    Gupta A, Khaira A, Singh B, Bhowmik DM, Tiwari SC.
    Clin Exp Nephrol; 2009 Aug 15; 13(4):402-403. PubMed ID: 19255825
    [No Abstract] [Full Text] [Related]

  • 18. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM.
    Rev Assoc Med Bras (1992); 2024 Aug 15; 70(4):e20230871. PubMed ID: 38716932
    [Abstract] [Full Text] [Related]

  • 19. Membranous lupus nephritis.
    Austin HA, Illei GG.
    Lupus; 2005 Aug 15; 14(1):65-71. PubMed ID: 15732291
    [Abstract] [Full Text] [Related]

  • 20. Membranous nephropathy: when and how to treat.
    Lai KN.
    Kidney Int; 2007 May 15; 71(9):841-3. PubMed ID: 17457329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.